Related references
Note: Only part of the references are listed.Cardinal Role of the Intrarenal Renin-Angiotensin System in the Pathogenesis of Diabetic Nephropathy
Hiroyuki Kobori et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes
Monika Buraczynska et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
Estimating Podocyte Number and Density Using a Single Histologic Section
Madhusudan Venkatareddy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Podocyte injury enhances filtration of liver-derived -angiotensinogen and renal angiotensin II generation
Taiji Matsusaka et al.
KIDNEY INTERNATIONAL (2014)
Podocyte Biology and Pathogenesis of Kidney Disease
Jochen Reiser et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Nox as a target for diabetic complications
Yves Gorin et al.
CLINICAL SCIENCE (2013)
Renin inhibition in the treatment of diabetic kidney disease
Radko Komers
CLINICAL SCIENCE (2013)
Modulating the endocannabinoid system in human health and disease successes and failures
Pal Pacher et al.
FEBS JOURNAL (2013)
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan et al.
NATURE MEDICINE (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Uric Acid Best Predicts Metabolically Unhealthy Obesity With Increased Cardiovascular Risk in Youth and Adults
Harald Mangge et al.
OBESITY (2013)
Angiotensin II Reduces Cardiac AdipoR1 Expression through AT1 Receptor/ROS/ERK1/2/c-Myc Pathway
Li Li et al.
PLOS ONE (2013)
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
Bela Horvath et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities
Robert J. Chorvat et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Joseph Tam et al.
CELL METABOLISM (2012)
Ibipinabant attenuates ß-cell loss in male Zucker diabetic fatty rats independently of its effects on body weight
K. Rohrbach et al.
DIABETES OBESITY & METABOLISM (2012)
Blockade of Cannabinoid Receptor 1 Improves Insulin Resistance, Lipid Metabolism, and Diabetic Nephropathy in db/db Mice
D. H. Nam et al.
ENDOCRINOLOGY (2012)
Interleukin 6 Underlies Angiotensin II-Induced Hypertension and Chronic Renal Damage
Weiru Zhang et al.
HYPERTENSION (2012)
Angiotensin II induces tumor necrosis factor-α expression and release from cultured human podocytes
Arianna Carolina Rosa et al.
INFLAMMATION RESEARCH (2012)
Angiotensin II Induces Vascular Endocannabinoid Release, Which Attenuates Its Vasoconstrictor Effect via CB1 Cannabinoid Receptors
Maria Szekeres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Hyperglycemia induces apoptosis via CB1 activation through the decrease of FAAH 1 in retianl pigment epithelial cells
Seul Ki Lim et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
The high glucose-induced stimulation of B1R and B2R expression via CB1R activation is involved in rat podocyte apoptosis
Seul Ki Lim et al.
LIFE SCIENCES (2012)
AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II
Raphael Rozenfeld et al.
EMBO JOURNAL (2011)
Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver
Bani Mukhopadhyay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Role of Angiotensin II in the Development of Nephropathy and Podocytopathy of Diabetes
Kirk N. Campbell et al.
CURRENT DIABETES REVIEWS (2011)
CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function
Vedat Tiyerili et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
Federica Barutta et al.
DIABETES (2010)
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
Tony Jourdan et al.
DIABETES (2010)
Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-γ
Bani Mukhopadhyay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction
Csaba Szabo
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Paracrine Transactivation of the CB1 Cannabinoid Receptor by AT1 Angiotensin and Other Gq/11 Protein-coupled Receptors
Gabor Turu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Analysis of the Relationship of Leptin, High-Sensitivity C-Reactive Protein, Adiponectin, Insulin, and Uric Acid to Metabolic Syndrome in Lean, Overweight, and Obese Young Females
Abdul Richa Abdullah et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2009)
The future of endocannabinoid-oriented clinical research after CB1 antagonists
Bernard Le Foll et al.
PSYCHOPHARMACOLOGY (2009)
Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells
Toru Kagawa et al.
NEPHROLOGY (2008)
Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats
P. Janiak et al.
KIDNEY INTERNATIONAL (2007)
Increased inflammatory biomarkers in hypertensive type 2 diabetic patients: improvement after angiotensin II type 1 receptor blockade
Rhian M. Touyz et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2007)
Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids
Christine Boerner et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
The effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes
Makoto Mizuno et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance
JM Ran et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol
P Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
NADPH oxidases in the kidney
Pritmohinder S. Gill et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Insight on the Pathogenesis of Diabetic Nephropathy from the Study of Podocyte and Mesangial Cell Biology
Gabriella Gruden et al.
CURRENT DIABETES REVIEWS (2005)
Vascular NAD(P)H oxidases:: specific features, expression, and regulation
B Lassègue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats
S Hoshi et al.
LABORATORY INVESTIGATION (2002)
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes
TM Coimbra et al.
KIDNEY INTERNATIONAL (2000)
Role of angiotensin II in diabetic nephropathy
DJ Leehey et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
